The new Express License service removes barriers to accessing this transformative gene editing technology for startups.An ...

An Express License provides fast, simple and affordable access to the CRISPR/Cas9 patent portfolio ... including life sciences research tools, kits and reagents; discovery of novel targets for ...

ErlySign’s innovation is a biomarker-based test kit capable of detecting oral precancerous conditions within just 15 minutes ...

Healthtech startup ErlySign has raised Rs 16 crore ($1.8 million) in its pre-Series A round from Ashish Kacholia. Snippets ...

Dublin, Jan. 13, 2025 (GLOBE NEWSWIRE) -- The "CRISPR-based Gene Editing Market by Product & Service, by Application, by End-User, and By Region" report has been added to ResearchAndMarkets.com's ...

Dublin, Jan. 13, 2025 (GLOBE NEWSWIRE) -- The "CRISPR-based Gene Editing Market by Product & Service, by Application, by End-User, and By Region" report has been added to ResearchAndMarkets.com's ...

(MENAFN- GlobeNewsWire - Nasdaq) Dublin, Jan. 13, 2025 (GLOBE NEWSWIRE) -- The "CRISPR-based Gene Editing market by Product & Service, by Application, by End-User, and By Region" report has been ...

According to the report, the CRISPR Genomic Cure Market will grow from US$ 3.18 Billion in 2023 to US$ 11.71 billion by 2030 at a compounded annual growth rate (CAGR) of 20.5% during the forecast ...

CRISPR-Cas9 is one of the biggest discoveries of the 21st century. Since it was developed in 2012, this gene-editing tool has revolutionized biology research, making it easier to study disease and ...